Expertise in
15
conditions

Dr. Alan Q. Thomas

Magnolia Cardiology Associates
Corinth, MS
Expertise in
15
conditions
Specialties:Sleep Medicine | Pulmonary Medicine | Intensive Care Medicine
Accepting New Patients
Offers Telehealth
Expertise in
15
conditions
OverviewInsuranceLocationsClinical Research

Overview

Alan Thomas is a Sleep Medicine specialist and a Pulmonary Medicine provider in Corinth, Mississippi. Dr. Thomas is highly rated in 15 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, Pleural Effusion, Pleurisy, and Excessive Daytime Sleepiness. Dr. Thomas is currently accepting new patients.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Sleep Medicine
Pulmonary Medicine
Intensive Care Medicine
Licenses
Critical Care Medicine in TX
Hospital Affiliations
Magnolia Regional Health Center
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Blue Cross Blue Shield
  •  Humana

Locations

MAGNOLIA CARDIOLOGY ASSOCIATES
611 Alcorn Dr, Suite 230, Corinth, MS 38834
662-287-5218

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
28
conditions
Dr. Felix A. Morris
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Expertise in
28
conditions
Dr. Felix A. Morris
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

Ecm Health Group LLC

1701 Veterans Dr, 
Florence, AL 
 (52.2 mi)
256-629-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Felix Morris is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Florence, Alabama. Dr. Morris is highly rated in 28 conditions, according to our data. His top areas of expertise are Lung Metastases, Obstructive Sleep Apnea, Pneumonia, Endoscopy, and Gastrostomy. Dr. Morris is currently accepting new patients.

Expertise in
33
conditions
Dr. Edsel P. Holden
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine
Expertise in
33
conditions
Dr. Edsel P. Holden
Pulmonary Medicine | Sleep Medicine | Intensive Care Medicine

The Lung Center, PC

3905 Peach St, 
Florence, AL 
 (53.1 mi)
256-767-5864
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Edsel Holden is a Pulmonary Medicine specialist and a Sleep Medicine provider in Florence, Alabama. Dr. Holden is highly rated in 33 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, Advanced Bronchoscopy, and Gastrostomy. Dr. Holden is currently accepting new patients.

Expertise in
18
conditions
Dr. Kumar P. Yogesh
Pulmonary Medicine | Sleep Medicine
Expertise in
18
conditions
Dr. Kumar P. Yogesh
Pulmonary Medicine | Sleep Medicine

Baptist Memorial Hospital-Booneville, Inc.

100 Hospital St, 
Booneville, MS 
 (19.2 mi)
662-720-5000
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Kumar Yogesh is a Pulmonary Medicine specialist and a Sleep Medicine provider in Booneville, Mississippi. Dr. Yogesh is highly rated in 18 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Asthma, and Asthma in Children. Dr. Yogesh is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile